Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Garry R Cutting

Showing results (131-140 of 158) with videos related to

Pageof 16
Sort By:
American Journal of Human Genetics|October 7, 2022
Pleiotropic modifiers of age-related diabetes and neonatal intestinal obstruction in cystic fibrosisMelis A Aksit, Hua Ling, Rhonda G Pace, et al.
American Journal of Human Genetics|October 5, 2022
MagicalRsq: Machine-learning-based genotype imputation quality calibrationQuan Sun, Yingxi Yang, Jonathan D Rosen, et al.
American Journal of Respiratory and Critical Care Medicine|March 20, 2019
Correlating Cystic Fibrosis Transmembrane Conductance Regulator Function with Clinical Features to Inform Precision Treatment of Cystic FibrosisAllison F McCague, Karen S Raraigh, Matthew J Pellicore, et al.
Human Mutation|April 12, 2017
Lessons from the CAGI-4 Hopkins clinical panel challengeJohn-Marc Chandonia, Aashish Adhikari, Marco Carraro, et al.
Plos Genetics|November 17, 2018
Capitalizing on the heterogeneous effects of CFTR nonsense and frameshift variants to inform therapeutic strategy for cystic fibrosisNeeraj Sharma, Taylor A Evans, Matthew J Pellicore, et al.
American Journal of Human Genetics|February 3, 2015
Gene expression in transformed lymphocytes reveals variation in endomembrane and HLA pathways modifying cystic fibrosis pulmonary phenotypesWanda K O'Neal, Paul Gallins, Rhonda G Pace, et al.
Pediatric Pulmonology|April 5, 2011
A novel lung disease phenotype adjusted for mortality attrition for cystic fibrosis genetic modifier studiesChelsea Taylor, Clayton W Commander, Joseph M Collaco, et al.
Molecular Biology of the Cell|January 30, 2016
From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutationsGudio Veit, Radu G Avramescu, Annette N Chiang, et al.
Hepatology (Baltimore, Md.)|March 27, 2024
Genetic variation in severe cystic fibrosis liver disease is associated with novel mechanisms for disease pathogenesisJaclyn R Stonebraker, Rhonda G Pace, Paul J Gallins, et al.
Human Mutation|November 30, 2020
Verifying nomenclature of DNA variants in submitted manuscripts: Guidance for journalsJan Higgins, Raymond Dalgleish, Johan T den Dunnen, et al.
Pageof 16

Showing results (131-140 of 158) with videos related to

Sort By:
Pageof 16
American Journal of Human Genetics|October 7, 2022
Pleiotropic modifiers of age-related diabetes and neonatal intestinal obstruction in cystic fibrosisMelis A Aksit, Hua Ling, Rhonda G Pace, et al.
American Journal of Human Genetics|October 5, 2022
MagicalRsq: Machine-learning-based genotype imputation quality calibrationQuan Sun, Yingxi Yang, Jonathan D Rosen, et al.
American Journal of Respiratory and Critical Care Medicine|March 20, 2019
Correlating Cystic Fibrosis Transmembrane Conductance Regulator Function with Clinical Features to Inform Precision Treatment of Cystic FibrosisAllison F McCague, Karen S Raraigh, Matthew J Pellicore, et al.
Human Mutation|April 12, 2017
Lessons from the CAGI-4 Hopkins clinical panel challengeJohn-Marc Chandonia, Aashish Adhikari, Marco Carraro, et al.
Plos Genetics|November 17, 2018
Capitalizing on the heterogeneous effects of CFTR nonsense and frameshift variants to inform therapeutic strategy for cystic fibrosisNeeraj Sharma, Taylor A Evans, Matthew J Pellicore, et al.
American Journal of Human Genetics|February 3, 2015
Gene expression in transformed lymphocytes reveals variation in endomembrane and HLA pathways modifying cystic fibrosis pulmonary phenotypesWanda K O'Neal, Paul Gallins, Rhonda G Pace, et al.
Pediatric Pulmonology|April 5, 2011
A novel lung disease phenotype adjusted for mortality attrition for cystic fibrosis genetic modifier studiesChelsea Taylor, Clayton W Commander, Joseph M Collaco, et al.
Molecular Biology of the Cell|January 30, 2016
From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutationsGudio Veit, Radu G Avramescu, Annette N Chiang, et al.
Hepatology (Baltimore, Md.)|March 27, 2024
Genetic variation in severe cystic fibrosis liver disease is associated with novel mechanisms for disease pathogenesisJaclyn R Stonebraker, Rhonda G Pace, Paul J Gallins, et al.
Human Mutation|November 30, 2020
Verifying nomenclature of DNA variants in submitted manuscripts: Guidance for journalsJan Higgins, Raymond Dalgleish, Johan T den Dunnen, et al.
Pageof 16